Publications

Articles in professional peer-reviewed journals

  1. Modrek, A. S., Golub, D., Khan, T., Bready, D., Prado, J., Bowman, C., Deng, J., Zhang, G., Rocha, P., Raviram, R., Lazaris, H., Stafford, J., LeRoy, G., Kader, M., Dhaliwal, J., Bayin, N. S., Frenster, J., Serrano, J., Chiriboga, L., Baitalmal, R., Chi, A., Golfinos, J. G., Wang, J., Karajannis, M., Bonneau, R., Reinberg, D., Tsirigos, A., Snuderl, M., Zagzag, D., Skok, J., Neubert, T., Placantonakis, D.G. Low-grade astrocytoma mutations in IDH1, P53 and ATRX cooperate to block differentiation of human neural stem cells via repression of SOX2. Cell Reports 2017; 21(5):1267-1280. doi: 10.1016/j.celrep.2017.10.009.
  2. Bayin, N.S., Frenster, J.D., Sen, R., Si, S., Modrek, A. S., Galifianakis, N., Dolgalev, I., Ortenzi, V., Illa-Bochaca, I., Khahera, A., Serrano, J., Chiriboga, L., Zagzag, D., Golfinos, J.G., Doyle, W., Heguy, A., Chesler, M., Barcellos-Hoff, M.H., Snuderl, M., Placantonakis, D.G. Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells. Oncotarget 2017; 8:64932-64953. doi: 10.18632/oncotarget.18117.
  3. Frenster, J.D., Inocencio, J. F., Xu, Z., Dhaliwal, J., Alghamdi, A., Zagzag, D., Bayin, N.S., Placantonakis, D.G. GPR133 promotes glioblastoma growth in hypoxia. Neurosurgery 2017; 64(CN_suppl_1):177-181. doi: 10.1093/neuros/nyx227
  4. Pourchet, A., Modrek, A.S., Placantonakis, D.G., Mohr, I., & Wilson, A.C. Modeling HSV-1 latency in human embryonic stem cell-derived neurons. Pathogens 2017; 6(2):24. doi:10.3390/pathogens6020024.
  5. Bayin, N.S., Frenster, J.D., Kane, J.R., Rubenstein, J., Modrek, A.S., Baitalmal, R., Dolgalev, I., Rudzenski, K., Snuderl, M., Golfinos, J.G., Doyle, W., Pacione, D., Parker, E.C., Chi, A.S., Heguy, A., MacNeil, D.J., Shohdy, N., Zagzag, D., Placantonakis, D.G. GPR133 (ADGRD1), an adhesion G protein-coupled receptor, is necessary for glioblastoma growth. Oncogenesis 2016; 5(10):e263. doi:10.1038/oncsis.2016.63.
  6. Bayin, N.S., Ma, L., Thomas, C., Baitalmal, R., Sure, A., Fansiwala, K., Bustoros, M., Golfinos, J.G., Pacione, D., Snuderl, M., Zagzag, D., Barcellos-Hoff, M.H., Placantonakis, D.G. Patient-specific screening using high-grade glioma explants to determine potential radiosensitization by a TGF-β small molecule inhibitor. Neoplasia 2016; 18:795-805.
  7. Tyagi, V., Theobald, J., Barger, J., Bustoros, M., Bayin, N.S., Modrek, A.S., Anderer, E., Donahue, B., Fatterpekar, G., Placantonakis, D.G. Traumatic Brain Injury and Subsequent Glioblastoma Development: Review of the Literature and Case Reports. Surgical Neurology International 2016; 7:78. doi: 10.4103/2152-7806.189296.
  8. Basu-Roy, U., Bayin, N. S., Rattanakorn, K., Han, E., Placantonakis, D.G., Mansukhani, A., & Basilico, C. SOX2 Antagonizes the Hippo Pathway to Maintain Stemness in Cancer Cells. Nature Communications 2015; 6:6411.
  9. Bayin, N. S., Modrek, A., Dietrich, A., Abel, T., Song, H.-R., Schober, M., Buchholz, C., Chao, M., Placantonakis, D.G. Selective Lentiviral Gene Delivery into CD133-expressing human Glioblastoma Stem Cells. PLoSOne 2014; 9:e116114.
  10. Bayin, N. S., Placantonakis, D.G. Heterogeneity and Diversity of Cancer Stem Cells in Glioblastoma. International Journal of Stem Cell Research and Therapy 2014; 1:001e.
  11. Bayin, N.S., Modrek, A. S., Placantonakis, D.G. Glioblastoma Stem Cells: Molecular Characteristics and Therapeutic Implications. World Journal of Stem Cells 2014; 6:230-238.
  12. Modrek, A. S., Bayin, N.S., Placantonakis, D.G. Stem cells as the cell of origin in glioma. World Journal of Stem Cells 2014; 6:43-52.